Jump to content

GeneXpert Infinity: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
not really distinct
AnomieBOT (talk | contribs)
Bots
6,527,560 edits
m Dating maintenance tags: {{Mergeto}}
Line 1: Line 1:
{{distinguish|GeneXpert MTB/RIF}}
{{distinguish|GeneXpert MTB/RIF}}
{{mergeto|Cepheid (company)}}
{{mergeto|Cepheid (company)|date=November 2021}}
The '''GeneXpert Infinity''' is an automated cartridge-based [[nucleic acid amplification test]] (NAAT) which is able to tell whether the subject fluid contains shreds of the [[Sars-CoV-2]] virus,<ref name="livfoi">{{cite news |title=Freedom of Information Act 2000 – Request for Information Reference: 7257 |url=https://www.aintreehospital.nhs.uk/media/12740/foi-7257-final-response.pdf |agency=Liverpool University Hospitals |issue=Our Ref: AC/JM/FOI 7257 |publisher=NHS Foundation Trust |date=7 January 2021}}</ref> amongst others.<ref name="durant19">{{cite journal |doi=10.1128/JCM.00619-19|title=Optimization of Turnaround Time for Group a Streptococcus PCR|year=2019|last1=Durant|first1=Thomas J. S.|last2=Merwede|first2=Jacob|last3=Reynolds|first3=Jesse|last4=Peaper|first4=David R.|journal=Journal of Clinical Microbiology|volume=57|issue=9|pmid=31217271|pmc=6711925}}</ref><ref name="dmid20">{{cite journal |doi=10.1016/j.diagmicrobio.2020.115062|title=Clinical evaluation of the Resistance ''Plus'' MG Fle ''Xible'' test on the Gene ''Xpert'' Infinity-48s instrument: A near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance|year=2020|last1=Fernández-Huerta|first1=Miguel|last2=Salmerón|first2=Paula|last3=Silgado|first3=Aroa|last4=Espasa|first4=Mateu|last5=Pumarola|first5=Tomàs|last6=Tulsiani-Drud|first6=Suhella|last7=Barberá|first7=María-Jesús|last8=Hoyos-Mallecot|first8=Yannick|last9=Serra-Pladevall|first9=Judit|journal=Diagnostic Microbiology and Infectious Disease|volume=97|issue=4|page=115062|pmid=32451118}}</ref><ref name="cassani18">{{cite journal |pmid=30799441|year=2018|last1=Cassani|first1=B.|last2=Soldano|first2=G.|last3=Finocchiaro|first3=D.|last4=Conti|first4=S.|last5=Bulfamante|first5=A.|last6=Lemorini|first6=G.|last7=Bulfamante|first7=G.|title=Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples|journal=Pathologica|volume=110|issue=4|pages=294–301}}</ref><ref name="chernesky17">{{cite journal |doi=10.1097/OLQ.0000000000000570|title=Comparison of cobas 4800, m2000, Viper XTR, and Infinity 80 Automated Instruments when Processing Urine Specimens for the Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae|year=2017|last1=Chernesky|first1=Max A.|last2=Jang|first2=Dan|last3=Gilchrist|first3=Jodi|last4=Smieja|first4=Marek|last5=Arias|first5=Manuel|last6=Hatchette|first6=Todd|last7=Poirier|first7=Andre|last8=Mayne|first8=Donna|last9=Ratnam|first9=Sam|journal=Sexually Transmitted Diseases|volume=44|issue=3|pages=161–165|pmid=28182591|s2cid=3636656}}</ref><ref name="jang16">{{cite journal |doi=10.1097/OLQ.0000000000000444|title=Comparison of Workflow, Maintenance, and Consumables in the Gene ''Xpert'' Infinity 80 and Panther Instruments While Testing for Chlamydia trachomatis and Neisseria gonorrhoeae|year=2016|last1=Jang|first1=Dan|last2=Ratnam|first2=Sam|last3=Gilchrist|first3=Jodi|last4=Arias|first4=Manuel|last5=Smieja|first5=Marek|last6=Mayne|first6=Donna|last7=Chernesky|first7=Max A.|journal=Sexually Transmitted Diseases|volume=43|issue=6|pages=377–381|pmid=27196259|s2cid=3656785}}</ref> It is manufactured by [[Cepheid Inc.]]
The '''GeneXpert Infinity''' is an automated cartridge-based [[nucleic acid amplification test]] (NAAT) which is able to tell whether the subject fluid contains shreds of the [[Sars-CoV-2]] virus,<ref name="livfoi">{{cite news |title=Freedom of Information Act 2000 – Request for Information Reference: 7257 |url=https://www.aintreehospital.nhs.uk/media/12740/foi-7257-final-response.pdf |agency=Liverpool University Hospitals |issue=Our Ref: AC/JM/FOI 7257 |publisher=NHS Foundation Trust |date=7 January 2021}}</ref> amongst others.<ref name="durant19">{{cite journal |doi=10.1128/JCM.00619-19|title=Optimization of Turnaround Time for Group a Streptococcus PCR|year=2019|last1=Durant|first1=Thomas J. S.|last2=Merwede|first2=Jacob|last3=Reynolds|first3=Jesse|last4=Peaper|first4=David R.|journal=Journal of Clinical Microbiology|volume=57|issue=9|pmid=31217271|pmc=6711925}}</ref><ref name="dmid20">{{cite journal |doi=10.1016/j.diagmicrobio.2020.115062|title=Clinical evaluation of the Resistance ''Plus'' MG Fle ''Xible'' test on the Gene ''Xpert'' Infinity-48s instrument: A near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance|year=2020|last1=Fernández-Huerta|first1=Miguel|last2=Salmerón|first2=Paula|last3=Silgado|first3=Aroa|last4=Espasa|first4=Mateu|last5=Pumarola|first5=Tomàs|last6=Tulsiani-Drud|first6=Suhella|last7=Barberá|first7=María-Jesús|last8=Hoyos-Mallecot|first8=Yannick|last9=Serra-Pladevall|first9=Judit|journal=Diagnostic Microbiology and Infectious Disease|volume=97|issue=4|page=115062|pmid=32451118}}</ref><ref name="cassani18">{{cite journal |pmid=30799441|year=2018|last1=Cassani|first1=B.|last2=Soldano|first2=G.|last3=Finocchiaro|first3=D.|last4=Conti|first4=S.|last5=Bulfamante|first5=A.|last6=Lemorini|first6=G.|last7=Bulfamante|first7=G.|title=Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples|journal=Pathologica|volume=110|issue=4|pages=294–301}}</ref><ref name="chernesky17">{{cite journal |doi=10.1097/OLQ.0000000000000570|title=Comparison of cobas 4800, m2000, Viper XTR, and Infinity 80 Automated Instruments when Processing Urine Specimens for the Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae|year=2017|last1=Chernesky|first1=Max A.|last2=Jang|first2=Dan|last3=Gilchrist|first3=Jodi|last4=Smieja|first4=Marek|last5=Arias|first5=Manuel|last6=Hatchette|first6=Todd|last7=Poirier|first7=Andre|last8=Mayne|first8=Donna|last9=Ratnam|first9=Sam|journal=Sexually Transmitted Diseases|volume=44|issue=3|pages=161–165|pmid=28182591|s2cid=3636656}}</ref><ref name="jang16">{{cite journal |doi=10.1097/OLQ.0000000000000444|title=Comparison of Workflow, Maintenance, and Consumables in the Gene ''Xpert'' Infinity 80 and Panther Instruments While Testing for Chlamydia trachomatis and Neisseria gonorrhoeae|year=2016|last1=Jang|first1=Dan|last2=Ratnam|first2=Sam|last3=Gilchrist|first3=Jodi|last4=Arias|first4=Manuel|last5=Smieja|first5=Marek|last6=Mayne|first6=Donna|last7=Chernesky|first7=Max A.|journal=Sexually Transmitted Diseases|volume=43|issue=6|pages=377–381|pmid=27196259|s2cid=3656785}}</ref> It is manufactured by [[Cepheid Inc.]]


Revision as of 17:58, 7 November 2021

Not to be confused with GeneXpert MTB/RIF.

The GeneXpert Infinity is an automated cartridge-based nucleic acid amplification test (NAAT) which is able to tell whether the subject fluid contains shreds of the Sars-CoV-2 virus,[1] amongst others.[2][3][4][5][6] It is manufactured by Cepheid Inc.

References

  1. ^ "Freedom of Information Act 2000 – Request for Information Reference: 7257" (PDF). No. Our Ref: AC/JM/FOI 7257. NHS Foundation Trust. Liverpool University Hospitals. 7 January 2021.
  2. ^ Durant, Thomas J. S.; Merwede, Jacob; Reynolds, Jesse; Peaper, David R. (2019). "Optimization of Turnaround Time for Group a Streptococcus PCR". Journal of Clinical Microbiology. 57 (9). doi:10.1128/JCM.00619-19. PMC 6711925. PMID 31217271.
  3. ^ Fernández-Huerta, Miguel; Salmerón, Paula; Silgado, Aroa; Espasa, Mateu; Pumarola, Tomàs; Tulsiani-Drud, Suhella; Barberá, María-Jesús; Hoyos-Mallecot, Yannick; Serra-Pladevall, Judit (2020). "Clinical evaluation of the Resistance Plus MG Fle Xible test on the Gene Xpert Infinity-48s instrument: A near-patient assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance". Diagnostic Microbiology and Infectious Disease. 97 (4): 115062. doi:10.1016/j.diagmicrobio.2020.115062. PMID 32451118.
  4. ^ Cassani, B.; Soldano, G.; Finocchiaro, D.; Conti, S.; Bulfamante, A.; Lemorini, G.; Bulfamante, G. (2018). "Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples". Pathologica. 110 (4): 294–301. PMID 30799441.
  5. ^ Chernesky, Max A.; Jang, Dan; Gilchrist, Jodi; Smieja, Marek; Arias, Manuel; Hatchette, Todd; Poirier, Andre; Mayne, Donna; Ratnam, Sam (2017). "Comparison of cobas 4800, m2000, Viper XTR, and Infinity 80 Automated Instruments when Processing Urine Specimens for the Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae". Sexually Transmitted Diseases. 44 (3): 161–165. doi:10.1097/OLQ.0000000000000570. PMID 28182591. S2CID 3636656.
  6. ^ Jang, Dan; Ratnam, Sam; Gilchrist, Jodi; Arias, Manuel; Smieja, Marek; Mayne, Donna; Chernesky, Max A. (2016). "Comparison of Workflow, Maintenance, and Consumables in the Gene Xpert Infinity 80 and Panther Instruments While Testing for Chlamydia trachomatis and Neisseria gonorrhoeae". Sexually Transmitted Diseases. 43 (6): 377–381. doi:10.1097/OLQ.0000000000000444. PMID 27196259. S2CID 3656785.
Stub icon

This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=GeneXpert_Infinity&oldid=1054037461"